Skip to main content
Article

FDA approves gene therapy for metachromatic leukodystrophy, the tenth for a genetic disease and the priciest yet

Nature Reviews Drug Discovery
DOI: 10.1038/d41573-024-00056-w
0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Mullard, A. (2024, May 1). FDA approves gene therapy for metachromatic leukodystrophy, the tenth for a genetic disease and the priciest yet. Nature Reviews Drug Discovery. Nature Research. https://doi.org/10.1038/d41573-024-00056-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free